Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...

A gene-editing drug developed by CRISPR Therapeutics ... by introducing a gene known as BCL11A which down-regulates the production of the adult form of the oxygen-carrying molecule.

Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...

Researchers have been "making great inroads" in precision medicine, and a 15 percent cap on indirect costs could quash the ...

Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...

Researchers developed a new gene-editing strategy that dramatically boosts the effectiveness of gene therapies in the liver, a breakthrough that could lead to new treatments for about 700 genetic ...

China issued guidelines on Friday to promote biotech cultivation, focusing on gene-editing tools and developing new wheat, ...

A team of Chinese scientists has used targeted gene editing to develop rice that produces coenzyme Q10 (CoQ10), a vital ...

When the gene editing tool CRISPR-Cas9 rocketed to fame more than a decade ago, it transformed biotechnology. Faster, cheaper, and safer than previous methods, the tool helped scientists gain insight ...

A gene variant present in most people might have contributed to cognitive differences between humans and their closest ...

Autophagy is the process by which cells digest and renew their internal structures, recycling damaged or malfunctioning ...